Enlivex Therapeutics Ltd (ENLV) Income Statement

Total revenue

--0.00

----

Revenue

--0.00

----

Operating expenses

-11.29%3.50M

-10.01%5.48M

-44.58%3.12M

-55.09%2.99M

-41.77%3.95M

-22.36%6.09M

-0.86%5.63M

13.25%6.65M

5.92%6.78M

0.40%7.84M

46.92%5.68M

54.18%5.87M

68.44%6.40M

111.36%7.81M

97.24%3.86M

70.53%3.81M

100.53%3.80M

30.22%3.70M

-7.64%1.96M

72.17%2.23M

-19.73%1.90M

353.71%2.84M

70.91%2.12M

52.95%1.30M

106.83%2.36M

-290.96%-1.12M

15.12%1.24M

-48.64%848.00K

-56.74%1.14M

-80.94%586.00K

-76.45%1.08M

-55.64%1.65M

-41.23%2.64M

-36.40%3.07M

27.63%4.58M

-0.43%3.72M

35.38%4.49M

51.17%4.83M

68.40%3.59M

236.15%3.74M

417.63%3.32M

--3.20M

--2.13M

--1.11M

--641.00K

R&D expenses

-10.75%2.55M

-23.20%3.42M

-46.01%2.35M

-60.30%2.00M

-44.80%2.86M

-21.89%4.45M

3.52%4.35M

22.51%5.04M

10.55%5.18M

10.34%5.70M

56.81%4.20M

61.87%4.11M

95.49%4.68M

140.06%5.17M

122.88%2.68M

86.69%2.54M

74.56%2.40M

14.83%2.15M

-23.73%1.20M

95.40%1.36M

-13.05%1.37M

--1.87M

50.81%1.58M

4.19%696.00K

71.90%1.58M

----

146.46%1.04M

-24.35%668.00K

-16.47%918.00K

-93.80%111.00K

-87.14%424.00K

-54.37%883.00K

-40.85%1.10M

-5.09%1.79M

92.47%3.30M

-9.66%1.94M

-4.82%1.86M

-7.82%1.89M

39.16%1.71M

197.09%2.14M

341.63%1.95M

--2.05M

--1.23M

--721.00K

--442.00K

Depreciation, depletion, and amortization

-52.13%90.00K

-82.00%36.00K

-24.77%161.00K

-24.53%160.00K

-10.05%188.00K

-9.50%200.00K

11.46%214.00K

20.45%212.00K

11.17%209.00K

47.33%221.00K

22.29%192.00K

44.26%176.00K

60.68%188.00K

50.00%150.00K

70.65%157.00K

103.33%122.00K

116.67%117.00K

51.52%100.00K

87.76%92.00K

-34.78%60.00K

22.73%54.00K

--66.00K

81.48%49.00K

318.18%92.00K

33.33%44.00K

----

--27.00K

-62.71%22.00K

560.00%33.00K

-100.00%0.00

742.86%59.00K

-16.67%5.00K

171.43%19.00K

50.00%6.00K

133.33%7.00K

100.00%6.00K

250.00%7.00K

100.00%4.00K

200.00%3.00K

--2.00K

--1.00K

Other operating expenses

----

-115950.00%-2.32M

----

-100.95%-2.00K

-74.36%10.00K

1.56%65.00K

-47.41%406.00K

-62.70%210.00K

-85.34%39.00K

--64.00K

--772.00K

--563.00K

--266.00K

----

--0.00

----

Operating profit

10.56%-3.53M

10.01%-5.48M

44.58%-3.12M

55.09%-2.99M

41.77%-3.95M

22.36%-6.09M

0.86%-5.63M

-13.25%-6.65M

-5.92%-6.78M

-0.40%-7.84M

-46.92%-5.68M

-54.18%-5.87M

-68.44%-6.40M

-111.36%-7.81M

-97.24%-3.86M

-70.53%-3.81M

-100.53%-3.80M

-30.22%-3.70M

7.64%-1.96M

-72.17%-2.23M

19.73%-1.90M

-353.71%-2.84M

-70.91%-2.12M

-52.95%-1.30M

-106.83%-2.36M

290.96%1.12M

-15.12%-1.24M

48.64%-848.00K

56.74%-1.14M

80.94%-586.00K

76.45%-1.08M

55.64%-1.65M

41.23%-2.64M

36.40%-3.07M

-27.63%-4.58M

0.43%-3.72M

-35.38%-4.49M

-51.17%-4.83M

-68.40%-3.59M

-236.15%-3.74M

-417.63%-3.32M

---3.20M

---2.13M

---1.11M

---641.00K

Net non-operating interest income (expenses)

Non-operating interest income

----

-63.23%456.00K

--517.00K

----

--11.00K

89.02%1.24M

----

--656.00K

----

671.93%440.00K

686.52%700.00K

-45.47%602.00K

-80.82%14.00K

-20.83%57.00K

134.21%89.00K

1907.27%1.10M

--73.00K

-48.57%72.00K

-88.13%38.00K

-58.33%55.00K

----

--140.00K

1423.81%320.00K

1550.00%132.00K

18.18%13.00K

----

50.00%21.00K

-70.37%8.00K

-45.00%11.00K

-79.49%8.00K

-74.55%14.00K

28.57%27.00K

-55.56%20.00K

105.26%39.00K

--55.00K

--21.00K

--45.00K

--19.00K

----

Non-operating interest expense

----

-23.08%110.00K

----

498.21%335.00K

-96.46%143.00K

-76.11%435.00K

----

--56.00K

--4.04M

--1.82M

----

2059.41%2.18M

-34.80%223.00K

344.06%897.00K

-99.44%2.00K

--101.00K

34100.00%342.00K

6633.33%202.00K

2286.67%358.00K

----

--1.00K

--3.00K

--15.00K

----

Gains from sale of securities

----

---4.00K

----

---2.00K

---4.00K

- Gains from disposal of fixed assets

85.57%-29.00K

96.44%-151.00K

--0.00

---201.00K

---4.24M

----

Other non-operating income (expenses)

--81.00K

----

--3.08M

----

Income before tax

16.62%-3.45M

43.09%-5.18M

56.36%-2.60M

54.42%-3.10M

42.64%-4.14M

-26.51%-9.10M

-4.01%-5.96M

31.48%-6.79M

12.24%-7.22M

-51.79%-7.19M

-67.44%-5.73M

-218.95%-9.91M

-157.03%-8.22M

19.24%-4.74M

-61.13%-3.42M

-2.20%-3.11M

-303.02%-3.20M

-104.53%-5.86M

11.13%-2.13M

-108.15%-3.04M

70.21%-794.00K

-629.94%-2.87M

-116.97%-2.39M

-175.14%-1.46M

-160.00%-2.67M

194.42%541.00K

-1.85%-1.10M

67.42%-531.00K

61.06%-1.02M

81.29%-573.00K

76.32%-1.08M

56.04%-1.63M

41.05%-2.63M

36.36%-3.06M

-28.80%-4.57M

-0.68%-3.71M

-35.43%-4.46M

-52.70%-4.81M

-68.07%-3.55M

-230.61%-3.68M

-411.16%-3.30M

---3.15M

---2.11M

---1.11M

---645.00K

Income tax

----

0.00%-4.00K

----

-140.00%-4.00K

-111.00%-11.00K

113.04%3.00K

-68.99%40.00K

-37.50%10.00K

3233.33%100.00K

-866.67%-23.00K

6350.00%129.00K

--16.00K

--3.00K

--2.00K

----

--0.00

Income after tax

16.62%-3.45M

43.09%-5.18M

56.36%-2.60M

54.42%-3.10M

42.64%-4.14M

-26.51%-9.10M

-4.01%-5.96M

31.48%-6.79M

12.24%-7.22M

-51.79%-7.19M

-67.44%-5.73M

-218.95%-9.91M

-157.03%-8.22M

19.24%-4.74M

-61.13%-3.42M

-2.20%-3.11M

-303.02%-3.20M

-104.53%-5.86M

11.13%-2.13M

-108.15%-3.04M

70.21%-794.00K

-626.06%-2.87M

-116.97%-2.39M

-175.14%-1.46M

-160.00%-2.67M

195.78%545.00K

-2.89%-1.10M

67.48%-531.00K

61.64%-1.02M

81.48%-569.00K

77.07%-1.07M

55.69%-1.63M

41.84%-2.67M

36.36%-3.07M

-31.51%-4.67M

0.03%-3.69M

-39.25%-4.59M

-53.20%-4.83M

-68.21%-3.55M

-230.88%-3.69M

-411.47%-3.30M

---3.15M

---2.11M

---1.11M

---645.00K

Net income from continuous operations

16.62%-3.45M

43.09%-5.18M

56.36%-2.60M

54.42%-3.10M

42.64%-4.14M

-26.51%-9.10M

-4.01%-5.96M

31.48%-6.79M

12.24%-7.22M

-51.79%-7.19M

-67.44%-5.73M

-218.95%-9.91M

-157.03%-8.22M

19.24%-4.74M

-61.13%-3.42M

-2.20%-3.11M

-303.02%-3.20M

-104.53%-5.86M

11.13%-2.13M

-108.15%-3.04M

70.21%-794.00K

-626.06%-2.87M

-116.97%-2.39M

-175.14%-1.46M

-160.00%-2.67M

195.78%545.00K

-2.89%-1.10M

67.48%-531.00K

61.64%-1.02M

81.48%-569.00K

77.07%-1.07M

55.69%-1.63M

41.84%-2.67M

36.36%-3.07M

-31.51%-4.67M

0.03%-3.69M

-39.25%-4.59M

-53.20%-4.83M

-68.21%-3.55M

-230.88%-3.69M

-411.47%-3.30M

---3.15M

---2.11M

---1.11M

---645.00K

Net income attributable to controlling interests

16.62%-3.45M

43.09%-5.18M

56.36%-2.60M

54.42%-3.10M

42.64%-4.14M

-26.51%-9.10M

-4.01%-5.96M

31.48%-6.79M

12.24%-7.22M

-51.79%-7.19M

-67.44%-5.73M

-218.95%-9.91M

-157.03%-8.22M

19.24%-4.74M

-61.13%-3.42M

-2.20%-3.11M

-303.02%-3.20M

-91.32%-5.86M

11.13%-2.13M

-108.15%-3.04M

70.21%-794.00K

-662.39%-3.06M

-116.97%-2.39M

-175.14%-1.46M

-160.00%-2.67M

195.78%545.00K

-2.89%-1.10M

67.48%-531.00K

61.64%-1.02M

81.48%-569.00K

77.07%-1.07M

55.69%-1.63M

41.84%-2.67M

36.36%-3.07M

-31.51%-4.67M

0.03%-3.69M

-39.25%-4.59M

-53.20%-4.83M

-68.21%-3.55M

-230.88%-3.69M

-411.47%-3.30M

---3.15M

---2.11M

---1.11M

---645.00K

Preferred share dividend

----

--198.00K

----

Net income attributable to common shareholders

16.62%-3.45M

43.09%-5.18M

56.36%-2.60M

54.42%-3.10M

42.64%-4.14M

-26.51%-9.10M

-4.01%-5.96M

31.48%-6.79M

12.24%-7.22M

-51.79%-7.19M

-67.44%-5.73M

-218.95%-9.91M

-157.03%-8.22M

19.24%-4.74M

-61.13%-3.42M

-2.20%-3.11M

-303.02%-3.20M

-91.32%-5.86M

11.13%-2.13M

-108.15%-3.04M

70.21%-794.00K

-662.39%-3.06M

-116.97%-2.39M

-175.14%-1.46M

-160.00%-2.67M

195.78%545.00K

-2.89%-1.10M

67.48%-531.00K

61.64%-1.02M

81.48%-569.00K

77.07%-1.07M

55.69%-1.63M

41.84%-2.67M

36.36%-3.07M

-31.51%-4.67M

0.03%-3.69M

-39.25%-4.59M

-53.20%-4.83M

-68.21%-3.55M

-230.88%-3.69M

-411.47%-3.30M

---3.15M

---2.11M

---1.11M

---645.00K

Basic earnings per share

32.15%-0.15

52.94%-0.23

61.86%-0.12

56.66%-0.16

43.29%-0.22

-25.45%-0.49

-2.86%-0.32

32.26%-0.37

12.94%-0.39

-50.80%-0.39

-66.71%-0.31

-217.75%-0.54

-130.59%-0.45

36.67%-0.26

-18.47%-0.19

24.96%-0.17

-178.75%-0.19

-37.20%-0.41

32.62%-0.16

-56.52%-0.23

98.74%-0.07

-120.11%-0.30

-92.64%-0.23

88.06%-0.14

-135.95%-5.51

208.66%1.48

95.26%-0.12

69.51%-1.21

64.16%-2.34

81.87%-1.36

77.51%-2.56

55.85%-3.97

48.66%-6.52

44.67%-7.51

-14.17%-11.40

13.21%-8.99

-36.97%-12.70

-138.62%-13.57

-53.66%-9.98

-156.48%-10.36

-284.91%-9.27

---5.69

---6.50

---4.04

---2.41

Diluted earnings per share

32.15%-0.15

52.94%-0.23

61.86%-0.12

56.66%-0.16

43.29%-0.22

-25.45%-0.49

-2.86%-0.32

32.26%-0.37

12.94%-0.39

-50.80%-0.39

-66.71%-0.31

-217.75%-0.54

-130.59%-0.45

36.67%-0.26

-18.47%-0.19

24.96%-0.17

-178.75%-0.19

-37.20%-0.41

32.62%-0.16

-56.52%-0.23

98.74%-0.07

-120.11%-0.30

-92.64%-0.23

88.06%-0.14

-135.95%-5.51

208.66%1.48

95.26%-0.12

69.51%-1.21

64.16%-2.34

81.87%-1.36

77.51%-2.56

55.85%-3.97

48.66%-6.52

44.67%-7.51

-14.17%-11.40

13.21%-8.99

-36.97%-12.70

-138.62%-13.57

-53.66%-9.98

-156.48%-10.36

-284.91%-9.27

---5.69

---6.50

---4.04

---2.41

Dividend per share

--0.00

----

--0.00

Currency unit

USD

Audit opinions

--

Enlivex Therapeutics Ltd

1.480USD

Enlivex Therapeutics Ltd

1.480

Overview

Company

Financials

Statements

Income Statement

Balance Sheet

Cash Flow Statement